Development of a new multiplex quantitative real-time PCR assay for the detection of the mtDNA4977 deletion in coronary artery disease patients: A link with telomere shortening

Environmental and Molecular Mutagenesis

Volumn 54, Issue 5, 2013, Pages 299-307

  Sabatino, Laura ^a   Botto, Nicoletta ^b   Borghini, Andrea ^a   Turchi, Stefano ^a   Andreassi, Maria Grazia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b G PASQUINUCCI HOSPITAL   (Italy)

Author keywords

Coronary artery disease; MtDNA4977 deletion; Telomere shortening

Indexed keywords

MITOCHONDRIAL DNA;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA EXTRACTION; DYSLIPIDEMIA; FEMALE; GENE DELETION; HEART MUSCLE BIOPSY; HUMAN; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SMOKING; TELOMERE; TELOMERE SHORTENING;

AGED; BASE SEQUENCE; CORONARY ARTERY DISEASE; DNA, MITOCHONDRIAL; FEMALE; GENETIC TESTING; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MULTIPLEX POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SEQUENCE DELETION; TELOMERE SHORTENING;

EID: 84878923733     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21783     Document Type: Article

References (38)

1. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG. 1981. Sequence and organization of the human mitochondrial genome. Nature 290:457-465.
2. Andreassi MG, Botto N. 2003. DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med 13:270-275.
3. Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC, McIntyre K, Runge MS. 2002. Mitochondrial integrity and function in atherogenesis. Circulation 106:544-549.
4. Ballinger SW, Patterson C, Yan CN, Doan R, Burow DL, Young CG, Yakes FM, Van Houten B, Ballinger CA, Freeman BA, Runge MS. 2000. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 86:960-966.
5. Bogliolo M, Izzotti A, De Flora S, Carli C, Abbondandolo A, Degan P. 1999. Detection of the '4977 bp' mitochondrial DNA deletion in human atherosclerotic lesions. Mutagenesis 14:77-82.
6. Botto N, Berti S, Manfredi S, Al-Jabri A, Federici C, Clerico A, Ciofini E, Biagini A, Andreassi MG. 2005. Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutat Res 570:81-88.
7. Cadenas E, Davies K. 2000. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29:222-230.
8. Cawthon RM. 2002. Telomere measurement by quantitative PCR. Nucleic Acid Res 30:e47.
9. Cawthon RM. 2009. Telomere length measurements by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 37:e21.
10. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. 1992. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 275:169-180.
11. Druzhyna NM, Wilson GL, LeDoux SP. 2008. Mitochondrial DNA repair in Aging and disease. Mech Ageing Dev 129:383-390.
12. Fischel-Ghodsian N, Bohlman MC, Prezant TR, Graham JM, Cerdebaum SD, Edwards MJ. 1994. Deletion in blood mitochondrial DNA in Kearns-Sayre syndrome. Biochim Biophys Acta 1226:37-43.
13. Izzotti A. 2009. Gene-environment interactions in non-cancer degenerative diseases. Mutat Res 667:1-3.
14. Izzotti A, Piana A, Minniti G, Vercelli M, Perrone L, De Flora S. 2007. Survival of atherosclerotic patients as related to oxidative stress and gene polymorphisms. Mutat Res 621:119-128.
15. Kim UK, Kim HS, Oh BH, Lee MM, Kim SH, Chae JJ, Choi HS, Choe SC, Lee CC, Park YB. 2000. Analysis of mitochondrial DNA deletions in four chambers of failing human heart: Hemodynamic stress, age, and disease are important factors. Basic Res Cardiol 95:163-171.
16. Knight-Lozano CA, Young CG, Burow DL, Hu ZY, Uyeminami D, Pinkerton KE, Ischiropoulos H, Ballinger SW. 2002. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 105:849-854.
17. Lai LP, Tsai CC, Su MJ, Lin JL, Chen YS, Tseng YZ, Huang SK. 2003. Atrial fibrillation is associated with accumulation of aging-related common type mitochondrial DNA deletion mutation in human atrial tissue. Chest 123:539-544.
18. Lee HC, Chang CM, Chi CW. 2010. Somatic mutations of mitochondrial DNA in aging and cancer progression. Ageing Res Rev 9:S47-S58.
19. Liu L, Trimarchi JR, Smith PJ, Keefe DL. 2002. Mitochondrial dysfunction leads to telomere attrition and genomic instability. Aging Cell 1:10-16.
20. Lu J, Sharma LK, Bay Y. 2009. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res 19:802-815.
21. Luft R. 1994. The development of mitochondrial medicine. Proc Natl Acad Sci USA 91:8731-8738.
22. Madamanchi NR, Runge MS. 2007. Mitochondrial dysfunction in atherosclerosis. Circ Res 100:460-73.
23. Mahmoudi M, Mercer J, Bennett M. 2006. DNA damage and repair in atherosclerosis. Cardiovasc Res 71:259-268.
24. Minamino T, Komuro I. 2008. Role of telomeres in vascular senescence. Front Biosci 13:2971-2979.
25. Mohamed SA, Hanke T, Erasmi AW, Bechtel MJF, Scharfschwerdt M, Meissner C, Sievers HH, Gosslau A. 2006. Mitochondrial DNA deletions and the aging heart. Exp Gerontol 41:508-517.
26. Olinski R, Gackowski D, Foksinski M, Rozalski R, Roszkowski K, Jaruga P. 2002. Oxidative DNA damage: Assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med 33:192-200.
27. Passos JF, Saretzki G, von Zglinicki T. 2007. DNA damage in telomeres and mitochondria during cellular senescence: Is there a connection? Nucleic Acid Res 35:7505-7513.
28. Passos JF, von Zglinicki T. 2005. Mitochondria, telomeres and cellular senescence. Exp Gerontol 40:466-472.
29. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acid Res 29:e45.
30. Puddu P, Puddu GM, Galletti L, Cravero E, Muscari A. 2005. Mitochondrial dysfunction as an initiating event in atherogenesis: A plausible hypothesis. Cardiology 10:137-141.
31. Saretzki G, Murphy MP, von Ziglinicki T. 2003. MitoQ counteracts telomere shortening and elongates lifespan of fibroblast under mild oxidative stress. Aging Cell 2:141-143.
32. Smith OP, Hamm MJ, Woodward CE, Brockington. 1995. Pearson's marrow/pancreas syndrome: Haematological features associated with deletion and duplication of mitochondrial DNA. Br J Haematol 90:469-472.
33. Tsutsui H, Ide T, Kinugawa S. 2006. Mitochondrial oxidative stress, DNA damage, and heart failure. Antioxid Redox Signal 8:1737-1744.
34. Tsutsui H, Kinugawa S, Matsushima S. 2009. Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 81:449-456.
35. von Ziglinicki T. 2002. Oxidative stress shortens telomeres. Trends Biochem Sci 27:339-344.
36. Wei YH. 1992. Mitochondrial DNA alterations as ageing-associated molecular events. Mutat Res 275:145-155.
37. Wei YH, Wu SB, Ma YS, Lee HC. 2009. Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging. Chang Gung Med J 32:113-32.
38. Yang Z, Harrison CM, Chuang GC, Ballinger SW. 2007. The role of tobacco smoke induced mitochondrial damage in vascular dysfunction and atherosclerosis. Mutat Res 621:61-74.